Pharmacologic properties of antihistamines in relation to vascular reactivity.
D000315:Adrenalectomy; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001775:Blood Circulation / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D002744:Chlorpheniramine / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008643:Mesentery; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D014666:Vasomotor System / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D010643:Phenoxybenzamine; D015016:Yohimbine; D012701:Serotonin; D002744:Chlorpheniramine; D001285:Atropine; D006632:Histamine; D004155:Diphenhydramine; D008012:Lidocaine; D011398:Promethazine; D007545:Isoproterenol; D002746:Chlorpromazine; D010646:Phentolamine